Showing 1 - 6 results of 6 for search 'K. Nasserinejad', query time: 0.02s
Refine Results
-
1
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia by P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin
Published 2023-07-01
Article -
2
P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110 by P. Hengeveld, Y. E. Ertem, J. Dubois, C. Mellink, A.-M. van der Kevie-Kersemaekers, L. Evers, K. Heezen, P. M. Kolijn, O. Mook, M. M. Motazacker, K. Nasserinejad, S. Kersting, P. Westerweel, C. Niemann, A. Kater, A. Langerak, M.-D. Levin
Published 2022-06-01
Article -
3
P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENST... by M.-A. Dimopoulos, K. Amaador, M. C. Minnema, K. Nasserinejad, M. Kap, E. Kastritis, M. Gavriatopoulou, W. Kraan, M. E. D. Chamuleau, D. Deeren, L. Tick, J. K. Doorduijn, F. Offner, L. H. Böhmer, R. D. Liu, S. T. Pals, J. M. Vos, M. J. Kersten
Published 2022-06-01
Article -
4
P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P... by K. Groen, C. Stege, K. Nasserinejad, K. de Heer, R. van Kampen, R. Leys, N. Thielen, M. Westerman, K. Wu, I. Ludwig, D. Issa, G. Velders, M. Vekemans, N. van de Donk, G. Timmers, F. de Boer, L. Tick, E. van der Spek, E. de Waal, M. Sohne, P. Sonneveld, I. Nijhof, S. Klein, M. Levin, P. Ypma, S. Zweegman
Published 2023-05-01
Article -
5
P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14... by K. Groen, M. Seefat, K. Nasserinejad, C. A. Stege, E. van der Spek, Y. M. Bilgin, A. Kentos, M. Sohne, R. J. van Kampen, I. Ludwig, N. Thielen, N. Durdu-Rayman, N. C. de Graauw, N. W. van de Donk, E. G. de Waal, M.-C. Vekemans, G. J. Timmers, M. van der Klift, S. Soechit, P. A. Geerts, M. H. Silbermann, M. Oosterveld, I. Nijhof, P. Sonneveld, S. K. Klein, M.-D. Levin, S. Zweegman
Published 2022-06-01
Article -
6
P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV) by M.R. Seefat, C.A.M. Stege, G.J. Timmers, M.D. Levin, M. Hoogendoorn, P.F. Ypma, I.S. Nijhof, G.A. Velders, L. Strobbe, N. Durdu-Rayman, M. Westerman, M.A. Davidis-van Schoonhoven, R.J.W. van Kampen, A. Beeker, A. Koster, A.C. Dijk, N.W.C.J. van de Donk, E. van der Spek, M.B.L. Leys, M.H. Silbermann, K. Groen, N.C.H.P. van der Burg-de Graauw, H.A.M. Sinnige, K.G. van der Hem, T.H. Levenga, Y.M. Bilgin, P. Sonneveld, S.K. Klein, K. Nasserinejad, H.M. Blommestein, D.G.J. Cucchi, B.I. Lissenberg-Witte, S. Zweegman
Published 2023-05-01
Article